颈部超声联合抑制性甲状腺球蛋白对全甲状腺切除及放射性碘消融治疗的低危甲状腺癌复发/持续病灶识别敏感性高,使刺激性甲状腺球蛋白检测不再必要
回顾性纳入148例全甲状腺切除及放射性碘消融后的低危分化型甲状腺癌患者,中位随访3.7年,持续/复发病灶8例(5.4%)。未刺激组72例中5例(6.9%)出现颈部结构性持续/复发;刺激组76例中刺激性甲状腺球蛋白未额外识别结构性病灶,但将3例(3.9%)归为生化持续/复发。抑制性和刺激性甲状腺球蛋白对持续/复发的阴性预测值分别为97%和100%。
要点
- 低危甲状腺癌术后随访中,颈部超声联合抑制性甲状腺球蛋白对持续/复发病灶的阴性预测值为97%。
- 颈部超声阴性且抑制性甲状腺球蛋白低于1 ng/mL时,加做刺激性甲状腺球蛋白不太可能识别临床重要病灶。
- 刺激性甲状腺球蛋白未额外识别结构性持续/复发病灶,仅将3例(3.9%)归为生化持续/复发。
核心结论
- 在全甲状腺切除及放射性碘消融治疗的低危甲状腺癌患者中,颈部超声联合抑制性或刺激性甲状腺球蛋白对持续/复发病灶具有相似的阴性预测值。颈部超声阴性且抑制性甲状腺球蛋白低于1 ng/mL时,加做刺激性甲状腺球蛋白不太可能识别临床重要病灶。
研究设计与样本
- 回顾性研究,纳入148例全甲状腺切除及放射性碘消融后的低危分化型甲状腺癌患者,中位随访3.7年;未刺激甲状腺球蛋白组72例(第1组),刺激甲状腺球蛋白组76例(第2组);以结构性或生化持续/复发为结局比较抑制性和刺激性甲状腺球蛋白的诊断性能。
关键影像表现/征象
- 第1组5例(6.9%)出现颈部结构性持续/复发,其中3例抑制性甲状腺球蛋白≥1 ng/mL、2例抑制性甲状腺球蛋白<1 ng/mL。
- 第1组4例接受手术、1例接受监测,5例在随访结束时抑制性甲状腺球蛋白均低于1 ng/mL。
- 第2组刺激性甲状腺球蛋白未识别额外的结构性持续/复发病例,但将3例(3.9%)归为生化持续/复发。
- 第2组3例中1例接受第二剂放射性碘治疗、2例接受监测,随访结束时均无病。
诊断标准与关键数值
- 抑制性甲状腺球蛋白对持续/复发的阴性预测值为97%。
- 刺激性甲状腺球蛋白对持续/复发的阴性预测值为100%。
- 持续/复发共8例(5.4%),其中结构性病灶5例、生化病灶3例。
临床应用与阅片要点
- 低危甲状腺癌全甲状腺切除及放射性碘消融后随访可联合颈部超声与抑制性甲状腺球蛋白评估持续/复发。
- 颈部超声阴性且抑制性甲状腺球蛋白低于1 ng/mL时,加做刺激性甲状腺球蛋白不太可能识别临床重要病灶。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Follow-up of patients with low-risk differentiated thyroid cancer treated with total thyroidectomy and radioiodine requires neck sonography and thyroglobulin (Tg). The need to stimulate Tg is controversial. The goal of this study was to compare the diagnostic performances of sonography plus suppressed or stimulated Tg in low-risk thyroid cancer.
METHODS: After total thyroidectomy and radioiodine, patients with low-risk thyroid cancer were retrospectively identified as having structural or biochemical persistence/recurrence. We compared the diagnostic performance of suppressed and stimulated Tg to detect persistence/recurrence.
RESULTS: We included 148 patients with low-risk thyroid cancer who were followed for a median of 3.7 years. Persistence/recurrence was found in 8 patients (5.4%; 5 structural disease and 3 biochemical disease). Thyroglobulin was not stimulated in 72 patients (group 1) and stimulated in 76 (group 2). In group 1, 5 patients (6.9%) had structural neck persistence/recurrence (3 with suppressed Tg ≥ 1 ng/mL and 2 with suppressed Tg < 1 ng/mL). Four patients underwent surgery, and 1 was surveilled. All 5 patients had suppressed Tg lower than 1 ng/mL at the end of follow-up. In group 2, stimulated Tg did not identify additional cases of structural persistence/recurrence but classified 3 patients (3.9%) as having biochemical persistence/recurrence. One patient received a second dose of radioiodine, and the other 2 were surveilled; all were without disease at the end of follow-up. Suppressed and stimulated Tg had negative predictive values for persistence/recurrence of 97% and 100%, respectively.
CONCLUSIONS: In low-risk thyroid cancer treated with total thyroidectomy and radioiodine, sonography and suppressed or stimulated Tg have similar negative predictive values for persistence/recurrence. Importantly, the coexistence of negative sonographic findings and suppressed Tg lower than 1 ng/mL makes the addition of stimulated Tg unlikely to identify clinically important disease.
引用
- Domínguez JM, Nilo F, Contreras T, et al. Neck Sonography and Suppressed Thyroglobulin Have High Sensitivity for Identifying Recurrent/Persistent Disease in Patients With Low-risk Thyroid Cancer Treated With Total Thyroidectomy and Radioactive Iodine Ablation, Making Stimulated Thyroglobulin Unnecessary. J Ultrasound Med. 2017. PMID: 28543974. doi:10.1002/jum.14260
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。